No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients. - Welzen, BJ; Mudrikova, T; Arends, JE; Hoepelman, AIM (HIV Medicine, 2012)